Karl Johnson

Karl Johnson is a Senior Medical Manager in HIV at Gilead Sciences, where they lead programs aimed at optimizing treatment outcomes for individuals with HIV. They collaborate with community organizations to co-design medical education focused on HIV treatment and holistic care while providing timely scientific updates to support these initiatives. Previously, Karl held senior program management roles at ACON, where they contributed to various HIV health programs and interventions. They hold a dual Master of Public Health and Master of Global Health from UNSW, graduating with excellence, and are committed to reducing stigma and improving access to care for people with HIV globally.